Codes / ICD10CM / C82.54

C82.54 Diffuse follicle center lymphoma, lymph nodes of axilla and upper limb

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Diffuse Follicle Center Lymphoma, Lymph Nodes of Axilla and Upper Limb

Summary

Diffuse follicle center lymphoma is a type of non-Hodgkin lymphoma that originates in the lymphatic system, specifically affecting B-cells. It is characterized by the proliferation of cancerous lymphocytes, which can accumulate in lymph nodes and other tissues. When localized to the lymph nodes of the axilla and upper limb, it typically involves the axillary, supraclavicular, or other regional lymph node groups in this area. This condition may present with varying clinical behavior, ranging from indolent to more aggressive forms.

Causes

The exact cause of diffuse follicle center lymphoma is not fully understood, but it is associated with genetic mutations in B-cells. Environmental factors and immune system dysfunction may contribute to its development.

Risk Factors

  • Age: More common in individuals over 60.
  • Family history: A history of lymphoma can increase risk.
  • Immune system deficiencies.
  • Certain infections, such as hepatitis C.

Symptoms

  • Painless swelling of lymph nodes in the axilla or upper limb.
  • Fatigue.
  • Night sweats.
  • Unexplained weight loss.
  • Fever.

Diagnosis

Diagnosis involves a physical examination, medical history review, blood tests, imaging studies (e.g., CT or PET scans), and a biopsy of affected lymph nodes to confirm the presence and subtype of lymphoma.

Treatment Options

  • Watchful waiting: Monitoring the condition without immediate treatment if symptoms are mild.
  • Radiation therapy: Targeted treatment for localized disease.
  • Chemotherapy: Systemic treatment for more extensive disease.
  • Immunotherapy: Targeted therapies to enhance the immune system's response.
  • Stem cell transplant: Considered for aggressive or relapsed cases.

Prognosis and Follow-Up

Prognosis varies based on the subtype, stage, and individual health factors. Regular follow-up with imaging and clinical assessments is essential to monitor for recurrence or progression. Early detection and appropriate treatment can improve outcomes.

Complications

  • Lymphoma progression or transformation to a more aggressive subtype.
  • Infection due to compromised immune function.
  • Side effects from treatment, such as fatigue or organ toxicity.

Lifestyle & Prevention

  • Maintain a healthy immune system through balanced nutrition and regular exercise.
  • Avoid known risk factors, such as smoking or excessive alcohol use.
  • Stay up-to-date with vaccinations to reduce infection risk.

When to Seek Professional Help

Seek medical attention if you experience persistent, painless lymph node swelling, unexplained weight loss, night sweats, or fatigue. Early evaluation is critical for timely diagnosis and management.

Tips for Medical Coders

Use code C82.54 for diffuse follicle center lymphoma localized to the lymph nodes of the axilla and upper limb. Ensure documentation specifies the anatomical site to support accurate coding. Review clinical notes for confirmation of the lymphoma subtype and location to align with coding guidelines.

Book a walkthrough

C82.54 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.